Who are Dimension Inx's investors?

Dimension Inx's investors include Better Ventures Central Llc, Lofty Ventures, Pathway Bioventures, Portal Innovations, Solas BioVentures, KdT Ventures.

How much funding has Dimension Inx raised?

Dimension Inx has disclosed $17.7M raised across 4 rounds.

Where is Dimension Inx headquartered?

Dimension Inx is headquartered in Chicago, US.

Dimension Inx

Chicago, US · Founded 2020 · Delaware corporation · 23 employees on LinkedIn · 6 known investors

Find your way into Dimension Inx

76 people in our graph share verified history with the Dimension Inx team — schools, employers, funds. One of them is your warm intro.

Blake Pattonunlockedknows Adam Jakus · together at Georgia Institute of Technology (overlapped)

×2knows the team · via Georgia Institute of Technology

×2knows the team · via Granite Creek Capital Partners, L.L.C.

knows the team · via Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA

×2knows the team · via Dimension Bio

×2knows the team · via University of Illinois College of Medicine

Dimension Bio is a biotechnology company that designs and manufactures regenerative therapeutics using its BioNidum™ platform to restore tissue function lost to disease, trauma, or aging. The platform combines materials science, 3D printing, and digital manufacturing to create biosynthetic and biohybrid scaffolds for implantable and injectable products across sports medicine, orthopedics, plastic surgery, dental, and cell therapy applications.

Biotech Healthtech New Materials

Founders & leadership

Dimension Inx was founded in 2020 by Caralynn Nowinski Collens, M.D., Ramille Shah, Ph.D., Ramille Shah, Caralynn Collens, and Adam Jakus.

Caralynn Nowinski Collens, M.D.inCo-founder & CEOCo-founder and CEO of Dimension Bio, a regenerative medicine company developing biosynthetic scaffolds using 3D printing and digital manufacturing. Dr. Collens holds an M.D. and has experience in building partnerships and commercializing biotechnology products across multiple therapeutic areas.

Ramille Shah, Ph.D.Co-founder & CSO

Ramille ShahCo-founder

Caralynn Collens inCo-founderCaralynn Collens is founder and CEO of Dimension Bio, a biotechnology company developing regenerative therapeutics using its BioNidum™ platform. She has advised corporate executives, entrepreneurs, university leaders, and government entities on innovation strategy.

Adam Jakus inCo-founderAdam Jakus is an engineering executive with approximately 15 years of experience in biomaterials design, tissue engineering, and additive manufacturing who has led the development and commercialization of 3D-printed regenerative medical products, including an FDA-cleared tissue regenerative medical device.

Board

Rima Chakrabartiin 𝕏Board directorPartner at KdT Ventures

Investors · 6

Better Ventures Central LlcOakland · $500K – $1.5M

Lofty VenturesChicago · $10K – $100K

Pathway BioventuresChicago

Portal InnovationsChicago

Solas BioVenturesChattanooga

KdT VenturesreportedAustin · $500K – $3M

Reported raises · per SEC filings

Form D private placements

$17.7M disclosed across 4 rounds · 2019–2023

▶$12MraisedFeb 2023 · 17 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Rima ChakrabartiDirector
Ramille ShahDirector
Caralynn CollensExecutive Officer, Director

Offering amount: $15M
Amount sold: $12M
First sale: Jan 2023
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2.3MraisedNov 2021 · 18 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Caralynn CollensExecutive Officer, Director
Ramille ShahExecutive Officer, Director
Adam JakusExecutive Officer, Director

Offering amount: $2.3M
Amount sold: $2.3M
First sale: Nov 2021
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$3.4MraisedNov 2020 · 22 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Caralynn CollensExecutive Officer, Director

Offering amount: $3.4M
Amount sold: $3.4M
First sale: Nov 2020
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$35KraisedDec 2019 · 1 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Adam JakusExecutive Officer, Director
Ramille ShahExecutive Officer, Director
Caralynn CollensExecutive Officer, Director

Amount sold: $35K
Minimum investment: $1
First sale: Dec 2019
Incorporated: Limited Liability Company, Delaware, 2016
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Dimension Inx went on to found or lead other companies.

Caralynn Nowinski Collens, M.D.Executive Officer, DirectorFounded Dimension Bio Adam JakusExecutive Officer, DirectorFounded Dimension Bio

Frequently asked questions

What does Dimension Inx do?: Dimension Bio is a biotechnology company that designs and manufactures regenerative therapeutics using its BioNidum™ platform to restore tissue function lost to disease, trauma, or aging. The platform combines materials science, 3D printing, and digital manufacturing to create biosynthetic and biohybrid scaffolds for implantable and injectable products across sports medicine, orthopedics, plastic surgery, dental, and cell therapy applications.
Who founded Dimension Inx?: Dimension Inx was founded by Caralynn Nowinski Collens, M.D., Ramille Shah, Ph.D., Ramille Shah, Caralynn Collens, Adam Jakus in 2020.
Who are Dimension Inx's investors?: Dimension Inx's investors include Better Ventures Central Llc, Lofty Ventures, Pathway Bioventures, Portal Innovations, Solas BioVentures, KdT Ventures.
How much funding has Dimension Inx raised?: Dimension Inx has disclosed $17.7M raised across 4 rounds.
Where is Dimension Inx headquartered?: Dimension Inx is headquartered in Chicago, US.